Tinavi Medical Stock Hits Day Low of CNY 24.60 Amid Price Pressure

Tinavi Medical Technologies Co., Ltd. experienced a notable decline today, with the stock dropping by 3.37% to reach an intraday low of CNY 24.60. This performance contrasts with the China Shanghai Composite, which fell by 1.26% on the same day. Over the past week, Tinavi has seen a decrease of 1.6%, while its monthly performance remains positive at 3.92%. Despite a strong yearly performance of 69.37%, the company faces challenges, including a low return on capital employed (ROCE) of 0% and negative net worth. The latest quarterly results indicate significant operational difficulties, with an operating profit margin of -89.45% and a pre-tax profit of CNY -53.81 million. Tinavi's market capitalization stands at CNY 8,502 million, categorizing it as a large-cap company in the Pharmaceuticals & Biotechnology sector. The stock's price-to-book ratio is 6.81, and it currently does not offer a dividend yield. The company's long-term growth prospects appear limited, with net sales growing at an annual rate of 13.49% and operating profit declining by 10.80% over the last five years.